Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry).
J ZitouniA-C BursztejnAnna Belloni FortinaA BeauchetV Di LerniaA LesiakJ ThomasZ TopkarciN MurashkinPiotr BrzezinskiTiago TorresAnca E ChiriacC LucaT McPhersonM AkindeA MaruaniR EpishevH Vidaurri de la CruzP C LunaM Amy de la BretêqueA LasekE BourratM BachelerieS MalletM SteffA BellissenI NeriEfterpi ZafiriouJ M P A van den ReekEnikö SonkolyS K MahilCatherine H SmithCarsten FlohrH BachelezEmmanuel Mahénull nullPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Biologics appear to be safe with no increased risk of severe form of COVID-19 in children with psoriasis. COVID-19 was responsible for the development of psoriasis or the worsening of a known psoriasis for some children.
Keyphrases